Mettler-toledo International, Inc. · NYSE:MTD

Mettler-toledo International — JP Morgan Healthcare Conference 2026

27 slides from Mettler-toledo International's conference presentation, Jan 12, 2026

  1. Slide 1: JP Morgan Healthcare Conference

    January 12, 2026 JP Morgan Healthcare Conference Patrick Kaltenbach, CEO

  2. Slide 2: Safe Harbor Statement

    Safe Harbor Statement 2 Statements in this presentation which are not historical facts constitute “forward looking statements” within the meaning of Section 27A of the U.S. Securities Act of 1933 and Section 21E of the U.S. Securities Exchange Act of 1934. These statements involve known and unknown

  3. Slide 3: Long Term Track Record of Performance

    Long Term Track Record of Performance 3 Growing Sales (1) Expanding Operating Margins (1) in mUSD 3,800 LC CAGR: 6% 31% +1,100 bps 28% 3,200 25% 2,600 22% 2,000 19% 14 15 16 17 18 19 20 21 22 23 24 14 15 16 17 18 19 20 21 22 23 24 Strong EPS Growth (1) 800 Excellent Shareholder Returns $45.00 700 CA

  4. Slide 4: End Markets and Applications We Serve

    End Markets and Applications We Serve 4 Balanced sales mix across attractive market segments  Life Sciences, Food Manufacturing, and Chemical markets represent over 70% of sales and benefit from favorable long-term structural growth drivers  Attractive end markets that reward automation and produc

  5. Slide 5: Diversified Geographies

    Diversified Geographies 5 We benefit from diversity and are well positioned for future trends and growth opportunities  Products sold in ~140 countries  Direct sales presence in ~40 countries  Well positioned to address growth in faster growing geographies  Emerging markets = ~33% of sales (Chin

  6. Slide 6: Our Innovative Solutions Across the Value Chain

    Our Innovative Solutions Across the Value Chain 6 Scale-up and Production R&D Laboratory Quality Control Lab Production and Filling Packing Logistics Food Retail Retail Process Industrial Product Logistics Laboratory Solutions Weighing Analytics Weighing Inspection Solutions Solutions We offer a bro

  7. Slide 7: Laboratory: Innovative Analysis for R&D Labs

    Laboratory: Innovative Analysis for R&D Labs 7 Highest precision and flexibility in analysis and measurement to accelerate our customers’ R&D Liquid Handling Analytical Instruments Automated Reactors Software Sample Preparation pH, Density and Refractometry, Melting and In Situ Analysis Automated da

  8. Slide 8: Laboratory: Support for Effective Quality Control

    Laboratory: Support for Effective Quality Control 8 Efficient processes in sample analysis and full support of the customers regulatory and documentation requirements Analytical Instruments Laboratory Weighing Liquid handling including Material Characterization Software Pipette Asset Management Titr

  9. Slide 9: Laboratory: Continuous Monitoring in Process Control

    Laboratory: Continuous Monitoring in Process Control 9 ISMTM (Intelligent Sensor Management) uses the power of digital sensors to help ensure process consistency, provide advanced data integration, and enable true predictive maintenance Process Analytics Water Analytics Gas Phase Analytics pH, O2, C

  10. Slide 10: Industrial: Comprehensive Solutions for Production

    Industrial: Comprehensive Solutions for Production 10 Tailored weighing solutions for production – from formulation to data management Weighing Terminals Bench and Floor Weigh Modules Logistics Software and Modules Scales and Load Cells Solutions

  11. Slide 11: Industrial: Product Inspection for Quality

    Industrial: Product Inspection for Quality 11 In-line detection of contamination and non-conformances in the production process ProdX Quality Metal Detection X-ray Inspection Checkweighing Management Software

  12. Slide 12: Competitive Advantages

    Competitive Advantages 12 Excellent brand, comprehensive Long history of innovation and Leader in fragmented markets product offering, installed base strong product portfolio Unique sophisticated sales and Direct sales network with excellent Superior and extensive global marketing programs applicati

  13. Slide 13: Spinnaker – Next Wave of Initiatives for Sales Excellence

    Spinnaker 6 – Next Wave of Initiatives for Sales Excellence 13  Spinnaker focuses on Sales, Marketing, and Service, comprised of initiatives and processes to accelerate sales growth and improve profitability - Increase demand for our products, solutions and services via Leads Generation and Sales F

  14. Slide 14: A Comprehensive Service Offering

    A Comprehensive Service Offering 14 Uptime Performance Compliance Expertise Technical Support Maintenance Quality Assurance Training and and Repair and Optimization and Certification Documentation Maximize productivity Yield the highest quality Comply with regulations Establish expertise  Ensure co

  15. Slide 15: Service Growth Drivers

    Service Growth Drivers 15 Service represents ~25% of sales and a significant growth opportunity iBase Penetration Selling Service at POS Service Excellence AI and Big Data Analytics Ensure Uptime and Satisfaction Maximize Productivity  Advanced iBase analysis  Value-Selling Service content for  A

  16. Slide 16: Continuous Innovation…

    Continuous Innovation… 16 ... to empower customer's ... to make results more ... to improve user interaction ... to support customers’ new discoveries precise and reliable digitalization needs  New insights through  New innovative sensors  Strong focus on ease of use  Software solutions powered

  17. Slide 17: Recent Innovation Examples

    Recent Innovation Examples 17 Multiparameter Excellence Level Digital Single AnyLevel Tank Benchtop Meter Laboratory Balances Use pH Sensor Weighing Sensors Scale-up and Production R&D Laboratory Quality Control Lab Production and Filling Packing Logistics LabX Software Compact Automation EVA Titrat

  18. Slide 18: Acquisition Strategy

    Acquisition Strategy 18 Select acquisitions to enhance leadership or expand offering, primarily focused on Life Sciences/ Biopharma tools, software, and distribution bolt-on’s Acquisition Strategy Close strategic gaps Technologies to complement Expand distribution channel (Product lines and geograph

  19. Slide 19: Margin Enhancement

    Margin Enhancement 19 Strong track record of continuous margin improvement Gross Margin Operating Margin (1) 61% 31% 60% Key Drivers: 29% 59%  Organic sales growth 27% 58%  Pricing program 25%  SternDrive initiatives 57% 23%  Blue Ocean 56%  Business mix 55% 21% 54% 19% 2014 2015 2016 2017 2018

  20. Slide 20: Global Supply Chain Overview

    Global Supply Chain Overview 20 Expand region-for-region setup for increased resilience, de-risking and to defend cost leadership  Global capabilities  Extensive footprint  Increased flexibility  Regional set-up  Blue Ocean enabled Production HUB Market Organization

  21. Slide 21: SternDrive Productivity & Cost Reduction Program

    SternDrive Productivity & Cost Reduction Program 21 Global program for operational excellence and continuous improvement Wave 3 Focus Topics:  Value engineering  Smart manufacturing  Process improvement  Should-cost analysis  Assembly line improvements  Sustainability  Spend management  Prev

  22. Slide 22: What Digitalization Means for METTLER TOLEDO

    What Digitalization Means for METTLER TOLEDO 22 Rapidly advancing capabilities with multiple solutions driving productivity and providing customer value Productivity / Insights:  Resource optimization enabled by digital planning tools Increased knowledge and visibility Expand  Insights and knowled

  23. Slide 23: Summary

    Summary 23 Significant Competitive Differentiators  Global leader in fragmented markets  Innovative product portfolio  Largest direct sales and service network with excellent application knowledge  Strong culture of execution and continuous improvement Well Developed & Ingrained Growth Strategie

  24. Slide 24: Thank You.

    METTLER TOLEDO 24 Thank You.

  25. Slide 25: Appendix: GAAP to Non-GAAP Measure Reconciliation

    Appendix 25 GAAP to Non-GAAP Measure Reconciliation Dollars in Millions 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 GAAP consolidated net sales 2,486 2,395 2,508 2,725 2,936 3,009 3,085 3,718 3,920 3,788 3,872 Local currency (LC) sales growth 5% 3% 7% 8% 6% 5% 2% 18% 11% (3%) 3% FX impact

  26. Slide 26: Non-GAAP financial measures: Adjusted Earnings per Share

    26 The presentation contains certain “non-GAAP financial measures” that the Company uses to supplements its U.S. GAAP results with non-GAAP financial measures, including Adjusted Earnings per Share and Adjusted Operating Profit. Adjusted Earnings per Share The Company defines Adjusted Earnings per S

  27. Slide 27: Adjusted Operating Profit

    27 Adjusted Operating Profit The Company defines Adjusted Operating Profit as gross profit less research and development and selling, general and administrative expenses before amortization, interest, restructuring charges and other charges (income), net and taxes. The most directly comparable U.S.

Mettler-Toledo International — JP Morgan Healthcare Conference 2026 on 6ix